{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:27:50Z","timestamp":1789846070394,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Pr\u00f3-Reitoria de Pesquisa da Universidade Federal de Minas Gerais"},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cellimm.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T02:23:32Z","timestamp":1527560612000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans"],"prefix":"10.1016","volume":"331","author":[{"given":"Patr\u00edcia A.F.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourena E.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana P.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethina T.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Machado-de-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2018.05.009_b0005","unstructured":"World Health Organization, Leishmaniasis. http:\/\/www.who.int\/topics\/leishmaniasis\/en\/, 2016."},{"key":"10.1016\/j.cellimm.2018.05.009_b0010","doi-asserted-by":"crossref","first-page":"e0005666","DOI":"10.1371\/journal.pntd.0005666","article-title":"Visceral leishmaniasis in an environmentally protected area in southeastern Brazil: epidemiological and laboratory cross-sectional investigation of phlebotomine fauna, wild hosts and canine cases","volume":"11","author":"Donalisio","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0015","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy \u2013 challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cellimm.2018.05.009_b0020","doi-asserted-by":"crossref","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","article-title":"Vaccines for visceral leishmaniasis: a review","volume":"422","author":"Jain","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cellimm.2018.05.009_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2016.07.004","article-title":"Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines","volume":"309","author":"Banerjee","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0035","doi-asserted-by":"crossref","first-page":"e0004614","DOI":"10.1371\/journal.pntd.0004614","article-title":"Recombinant forms of Leishmania amazonensis excreted\/secreted promastigote surface antigen (PSA) induce protective immune responses in dogs","volume":"10","author":"Petitdidier","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-017-0025-5","article-title":"A defined subunit vaccine that protects against vector-borne visceral leishmaniasis","volume":"21","author":"Duthie","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.cellimm.2018.05.009_b0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fimmu.2012.00099","article-title":"Vaccine development against Leishmania donovani","volume":"3","author":"Das","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0055","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2018.05.009_b0060","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","article-title":"Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections","volume":"9","author":"Zanin","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cellimm.2018.05.009_b0065","doi-asserted-by":"crossref","first-page":"e51181","DOI":"10.1371\/journal.pone.0051181","article-title":"Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania","volume":"7","author":"Todol\u00ed","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2018.05.009_b0070","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijantimicag.2010.06.024","article-title":"Leishmaniasis vaccines: past, present and future","volume":"1","author":"Modabber","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.cellimm.2018.05.009_b0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molimm.2016.06.014","article-title":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","volume":"76","author":"Duarte","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12026-013-8400-4","article-title":"Adverse events following immunization with vaccines containing adjuvants","volume":"56","author":"Cerpa-Cruz","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cellimm.2018.05.009_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pep.2016.10.008","article-title":"Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis","volume":"130","author":"McAtee","year":"2017","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.cellimm.2018.05.009_b0090","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2018.05.009_b0095","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2018.05.009_b0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.exppara.2015.03.027","article-title":"Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis","volume":"153","author":"Jesus-Pereira","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0105","first-page":"35","article-title":"Bivalent DNA vaccination with genes encoding Leishmania major cysteine proteinases type I and II protects mice against infectious challenge","volume":"2","author":"Zadeh-Vakili","year":"2004","journal-title":"Iran J. Biotechnol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/pim.12310","article-title":"Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB\/c mice","volume":"38","author":"Maspi","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3389\/fmicb.2017.01263","article-title":"Recombinant invasive <i>Lactococcus lactis<\/i> carrying a DNA vaccine coding the Ag85A antigen increases INF-\u03b3, IL-6, and TNF-\u03b1 cytokines after intranasal immunization","volume":"8","author":"Mancha-Agresti","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molimm.2017.12.015","article-title":"VP2 (PTA motif) encoding DNA vaccine confers protection against lethal challenge with infectious pancreatic necrosis virus (IPNV) in trout","volume":"94","author":"Ahmadivand","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/pim.12315","article-title":"DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control","volume":"38","author":"Kumar","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0135","doi-asserted-by":"crossref","first-page":"e1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cellimm.2018.05.009_b0145","article-title":"Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis","volume":"20","author":"Portela","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2018.05.009_b0150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7555\/JBR.30.20150125","article-title":"Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB\/c mice","volume":"30","author":"Kaur","year":"2016","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.cellimm.2018.05.009_b0155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb\/c mice","volume":"82","author":"Amit","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vetpar.2015.07.005","article-title":"Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis","volume":"212","author":"Shahbazi","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0165","article-title":"Phlebotomus papatasi yellow-related and apyrase salivary proteins are candidates for vaccination against human cutaneous Leishmaniasis","volume":"17","author":"Tlili","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0170","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.165.2.915","article-title":"Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells","volume":"165","author":"Gurunathan","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molimm.2018.03.004","article-title":"Immunomodulation induced through ornithine decarboxylase DNA immunization in Balb\/c mice infected with Leishmania donovani","volume":"97","author":"Kumar","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0180","doi-asserted-by":"crossref","first-page":"e0003751","DOI":"10.1371\/journal.pntd.0003751","article-title":"Coadministration of the three antigenic Leishmania infantum poly (a) binding proteins as a DNA vaccine induces protection against leishmania major infection in BALB\/c mice","volume":"9","author":"Soto","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0185","doi-asserted-by":"crossref","first-page":"2145386","DOI":"10.1155\/2017\/2145386","article-title":"Immune response and protective efficacy of a heterologous DNA-protein immunization with <i>Leishmania<\/i> superoxide dismutase B1","volume":"2017","author":"Bayih","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cellimm.2018.05.009_b0190","doi-asserted-by":"crossref","first-page":"e108556","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2018.05.009_b0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.molimm.2017.09.010","article-title":"Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7\/8 in a vaccine against leishmaniasis in BALB\/c mice","volume":"91","author":"Rostamian","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0200","article-title":"Recombinant prohibition protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"9","author":"Dias","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0205","doi-asserted-by":"crossref","first-page":"e12359","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4\u00b1 and CD8+ T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00114-001-0270-2","article-title":"DNA vaccines","volume":"88","author":"Gregersen","year":"2001","journal-title":"Naturwissenschaften."},{"key":"10.1016\/j.cellimm.2018.05.009_b0215","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/4000","article-title":"Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection","volume":"4","author":"Gurunathan","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2018.05.009_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.05.028","article-title":"Pulmonary DNA vaccination: concepts, possibilities and perspectives","volume":"107","author":"Bivas-Benita","year":"2005","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.cellimm.2018.05.009_b0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00005-007-0044-4","article-title":"DNA vaccines: are they still just a powerful tool for the future?","volume":"55","author":"Bel\u00e1kov\u00e1","year":"2007","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.cellimm.2018.05.009_b0230","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.vaccine.2016.04.067","article-title":"Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis","volume":"34","author":"Duthie","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2018.05.009_b0235","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.vaccine.2009.11.075","article-title":"Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively","volume":"28","author":"Meddeb-Garnaoui","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2018.05.009_b0240","doi-asserted-by":"crossref","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1874091X01711010105","article-title":"Inflammatory markers and plasma lipids in HIV patients: a correlation analysis study","volume":"11","author":"Muswe","year":"2017","journal-title":"Open Biochem. J."},{"key":"10.1016\/j.cellimm.2018.05.009_b0250","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cimid.2017.12.001","article-title":"Association of TNF-\u03b1, IL-10 and IL-6 promoter polymorphisms in pulmonary tuberculosis patients and their household contacts of younger age group","volume":"56","author":"Joshi","year":"2018","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0255","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s13071-017-2576-8","article-title":"Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection","volume":"10","author":"Ramos","year":"2017","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.cellimm.2018.05.009_b0260","doi-asserted-by":"crossref","first-page":"e0004415","DOI":"10.1371\/journal.pntd.0004415","article-title":"Combined immune therapy for the treatment of visceral leishmaniasis","volume":"10","author":"Faleiro","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-5-113","article-title":"Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis","volume":"5","author":"Caldas","year":"2005","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0270","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.trstmh.2012.07.005","article-title":"Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis","volume":"106","author":"Mukhopadhyay","year":"2012","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cellimm.2018.05.009_b0275","doi-asserted-by":"crossref","first-page":"e3273","DOI":"10.1371\/journal.pntd.0003273","article-title":"IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test","volume":"8","author":"Bhattacharyya","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.05.009_b0280","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-3024.2008.01036.x","article-title":"Elevated levels of IgG3 and IgG4 subclass in paediatric cases of kala-azar","volume":"30","author":"Ansari","year":"2008","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2018.05.009_b0285","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CVI.00149-06","article-title":"Use of immunoglobulin G avidity to determine the course of disease in visceral and post-kala-azar dermal leishmaniasis patients","volume":"13","author":"Redhu","year":"2006","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874918301278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874918301278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:58:05Z","timestamp":1757804285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874918301278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":57,"alternative-id":["S0008874918301278"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2018.05.009","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}